Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.890
-0.070 (-3.57%)
At close: Jul 13, 2026, 4:00 PM EDT
1.920
+0.030 (1.59%)
Pre-market: Jul 14, 2026, 8:17 AM EDT
Palisade Bio Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +270.37% | Jun 30, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $8 | Buy | Reiterates | $8 | +323.28% | Jun 30, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Reiterates $7 | Buy | Reiterates | $7 | +270.37% | Jun 2, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $25 | Buy | Reiterates | $25 | +1,222.75% | Apr 13, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $7 | Buy | Initiates | $7 | +270.37% | Apr 8, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $1.78 → $5 | Buy | Maintains | $1.78 → $5 | +164.55% | Apr 4, 2026 |
| Clear Street | Clear Street | Buy Maintains $12 | Buy | Maintains | $12 | +534.92% | Mar 31, 2026 |